Rockwell Medical, Inc. cash flow to debt ratio of -5.28% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Rockwell Medical, Inc.'s free cash flow has decreased 137.64% from $3.19M last year to $-1.20M, signaling decreasing performance

Rockwell Medical, Inc.'s debt to equity ratio is 0.40, which means that the company's assets are healthy financed, signaling financial stability.

Rockwell Medical, Inc.'s debt has decreased relative to shareholder equity from 0.42 last year to 0.40 today, signaling strengthened financials

Rockwell Medical, Inc. has a net cash position, so leverage is healthy.

Rockwell Medical, Inc.'s interest coverage ratio is -4.26, which means that the company struggles to meet interest obligations, signaling financial risk.

Rockwell Medical, Inc.'s profit margin has decreased (1.59K%) in the last year from -0.47% to -7.98%, signaling decreasing performance

Rockwell Medical, Inc.'s short-term assets of $38.16M exceed its short-term liabilities of $9.58M

Rockwell Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Rockwell Medical, Inc.'s return on equity of -15.41%, is lower than 15.00%, indicating bad performance

Rockwell Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Rockwell Medical, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Rockwell Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Rockwell Medical, Inc. has negative free cash flow, indicating cash burn

Rockwell Medical, Inc.'s yearly earnings has decreased 1.01K% since last year from $-480.00K to $-5.31M, signaling decreasing performance

Rockwell Medical, Inc.'s yearly revenue has increased 68.14K% since last year from $101.49M to $69.26B, signaling increasing performance

ROIC -9.57% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Rockwell Medical, Inc.'s 3-year revenue CAGR of -1.65% is negative, indicating declining revenue over the past 3 years

Rockwell Medical, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Rockwell Medical, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Rockwell Medical, Inc. is undervalued relative to its fair value price of 633.50 based on Discounted Cash Flow model

Rockwell Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Rockwell Medical, Inc. is undervalued relative to its fair value price of 633.60 based on EBITDA multiple model

Rockwell Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Rockwell Medical, Inc. has insufficient data to evaluate this check.

Rockwell Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Rockwell Medical, Inc. has a price-to-book ratio of 0.75x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Rockwell Medical, Inc. has a price-to-sales ratio of 0.40x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue